AXS Investments’s Chemed CHE Stock Holding History

AXS Investments’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-310	Closed	-$181K	–	319
2023 Q4	$181K	Buy	+310	New	+$173K	0.04%	295
2023 Q2	–	Sell	-295	Closed	-$159K	–	429
2023 Q1	$159K	Buy	+295	New	+$150K	0.05%	227

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

AXS Investments's CHE Position: Q1 2024 in Review

AXS Investments sold out of Chemed (CHE) in Q1 2024, closing a stake of 310 shares — an estimated $181K sold.

AXS Investments first reported a position in CHE in Q1 2023 and held it in 2 quarters. The position peaked at $181K in Q4 2023. 511 funds tracked by Wall St. Rank hold CHE as of Q1 2024.

AXS Investments reported no remaining Chemed position as of Q1 2024 after selling out during the quarter.
AXS Investments sold 310 Chemed shares in Q1 2024, an estimated $181K.
AXS Investments first reported a position in Chemed in Q1 2023 and held it in 2 quarters.
AXS Investments's Chemed position peaked at $181K in Q4 2023.
511 funds tracked by Wall St. Rank held Chemed as of Q1 2024.

Based on AXS Investments's 13F filing for Q1 2024, filed 13 May 2024.